Search hospitals > North Carolina > Huntersville
Novant Health Cancer Institute - Huntersville
Claim this profileHuntersville, North Carolina 28078
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Recurrence
33 reported clinical trials
6 medical researchers
Summary
Novant Health Cancer Institute - Huntersville is a medical facility located in Huntersville, North Carolina. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Novant Health Cancer Institute - Huntersville is involved with conducting 33 clinical trials across 123 conditions. There are 6 research doctors associated with this hospital, such as Alan Skarbnik, MD, Obiageli U. Ogbata, Kimberly S. Strickland, and Kevin S. Roof.Area of expertise
1Cancer
Global LeaderStage I
Stage IV
Stage II
2Breast Cancer
Global LeaderER positive
HER2 positive
HER2 negative
Top PIs
Alan Skarbnik, MDNovant Health Presbyterian Medical Center5 years of reported clinical research
Studies Lymphoma
Studies Chronic B-Cell Leukemia
8 reported clinical trials
16 drugs studied
Obiageli U. OgbataNovant Health Presbyterian Medical Center3 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
4 reported clinical trials
8 drugs studied
Kimberly S. StricklandNovant Health Presbyterian Medical Center1 year of reported clinical research
Studies Breast Cancer
Studies Cancer
5 reported clinical trials
17 drugs studied
Kevin S. RoofNovant Health Presbyterian Medical Center5 years of reported clinical research
Studies Lung Cancer
Studies Squamous Cell Carcinoma
3 reported clinical trials
12 drugs studied
Clinical Trials running at Novant Health Cancer Institute - Huntersville
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Ovarian Tumors
Ovarian Carcinoma
Testicular Carcinoma
Ovarian Choriocarcinoma
Cancer
Germ Cell Tumors
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Novant Health Cancer Institute - Huntersville?
Novant Health Cancer Institute - Huntersville is a medical facility located in Huntersville, North Carolina. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Novant Health Cancer Institute - Huntersville is involved with conducting 33 clinical trials across 123 conditions. There are 6 research doctors associated with this hospital, such as Alan Skarbnik, MD, Obiageli U. Ogbata, Kimberly S. Strickland, and Kevin S. Roof.